Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The Cheilectomy market has witnessed notable growth in recent years, driven by the rising prevalence of osteoarthritis and other joint-related conditions. Cheilectomy, a surgical procedure aimed at treating hallux rigidus by removing bone spurs, has become a preferred choice for many patients seeking relief from foot pain and limited joint mobility.
Among many more driving forces to the expansion of the Cheilectomy market is falling number of hallux rigidus cases, a condition with a hallmark of pain and stiffness at the big toe joints. Infantilization of the population and increase in sedentary lifestyle are the main reasons of hallux rigidus, which necessitates treatment options like cheilectomy because of the demand.
Surgical techniques progresses have influenced highly the cheilectomy market till this time. Minimally invasive surgeries, more precise technology, and better imaging machines have raised the chances of the success of Cheilectomy surgeries which then can lead the patients and healthcare professionals to attract the patients.
Along with an expanding liveability influenced by the heightened awareness about foot conditions, together with an aggressive patient education, has been a crucial factor for the market's growth. Information improves the level of awareness of patients about treatment among which Cheilectomy is commonly used and patients share decision making with their healthcare providers on further treatment.
Rise of overall global healthcare expenditures has somehow improved the performance of Cheilectomy device industry. Market growth is fueled by patients deciding to spend on richly constructed and multi-functional treatments for afoots, which are among the most popular solutions.
The demographic of aging people, especially in the developed region, has resulted in see the renewal of the foot disorders and include hallux rigidus. As aged individuals are seeking a way to remain an active role, in orthopedics, Cheilectomy stands as a possible solution, aiding the sales feat.
Though the procedures possess promising advancements, still the Cheilectomy market is confronted by some challenges such as lack of affordable healthcare in few underdeveloped regions and reimbursement issues. Nevertheless, the mentioned challenges create chances for the market players to improve and build up methods which will help facing the problems and to widen the placing of the market players.
Looking ahead, ongoing research and development initiatives are expected to bring forth further innovations in Cheilectomy procedures. The integration of technologies such as robotics and artificial intelligence in surgical practices holds promise for improving surgical outcomes and patient experiences, shaping the future trajectory of the Cheilectomy market.
Cheilectomy Market Highlights:
Global Cheilectomy Market Overview
Cheilectomy Market Size was valued at USD 3.42 Billion in 2023. The Global Cheilectomy industry is projected to grow from USD 3.71 Billion in 2024 to USD 8.82 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.62% during the forecast period (2024 - 2032).
Cheilectomy is a surgical procedure aimed to remove the bony lump present on the top of the metatarsophalangeal joint (big toe). Hallux rigidus, a type of big toe arthritis is a major cause of the same. According to a study published in the World Journal of Orthopedics in 2017, hallux rigidus is a degenerative disease of the first MTP joint. Moreover, it is estimated that the disease affects 1 in every 40 people, aged 50 or more.
Females are greatly affected by the disease as compared to males, .i.e., by a ratio of 2:1. Therefore, increasing prevalence of hallux rigidus and growing female population are the major drivers for the market growth during the forecast period. Additionally, increasing demands for minimally invasive procedures and rising healthcare expenditure is estimated to fuel the market.
According to the World Health Organization, the geriatric population is projected to grow from an estimated 524 million in 2010 to approximately 1.5 billion by 2050. However, high procedural cost followed by complications like deep vein thrombosis, need for repeated surgery, stiffness in the joints of the toes and low per capita healthcare expenditure in the middle and low-income countries is estimated to restrain the market growth during the projected period. According to the Fairfield Independent Hospital, the procedural cost for the same in 2016 was estimated to be around USD 3,545.
Intended Audience
- Pharmaceutical Companies
- Biotechnological Institutes
- Government and Private Laboratories
- Research and Development (R&D) Companies
- Medical Research Laboratories
- Market Research and Consulting Service Providers
Figure 1:- Global Cheilectomy Market Share, by Region
Sources: WHO, annual reports, press release, white paper, and company presentation
Global Cheilectomy Market Segmentation
The cheilectomy market is segmented by the method, anesthesia, medication, and end-user.
By the method, the cheilectomy market is segmented into open, arthroscopic, and percutaneous method.
By the anesthesia, the cheilectomy market is categorized into general anesthesia, local anesthesia, and regional anesthesia. By the medication, the market is segmented into prescription pain relievers, OCT, and others. By prescription the pain relievers the market is segmented into corticosteroids, opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and others. By the OCT drugs, the market is segmented into ibuprofen, naproxen, and others. By end users, the market is segmented into hospitals & clinics, academic institutes, retail pharmacies, and others.
Global Cheilectomy Market Regional Analysis
The Americas dominate the cheilectomy market owing to a well-developed healthcare sector and increasing the prevalence of hallux rigidus. Moreover, increasing healthcare expenditure and presence of the key players within the regions boosts the growth of the market in the Americas. Additionally, increasing geriatric population and growing female population fuels the regional market growth.
Europe is the second largest cheilectomy market, which is followed by Asia Pacific. Osteoarthritis is a common condition that may lead to hallux rigidus. Thus, increasing prevalence of the disease within the region drives the market growth. According to the Arthritis Research U.K in 2013, osteoarthritis was estimated to be the most common musculoskeletal condition in the geriatric population. Additionally, it was estimated that approximately, 8.75 million people within the region had sought some treatment for osteoarthritis.
Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India & China, and presence of huge opportunity in the market.
On the other hand, the Middle East & Africa has the least share in the cheilectomy market due to the presence of poor economy, especially in the Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.
Research Methodology
Sources: WHO, annual reports, press release, white paper, and company presentation
Key Players in Cheilectomy Market
The key players for the cheilectomy market are:
- Henry Schein, Inc. (U.S.)
- STEROID S.p.A. (Italy)
- Pfizer Inc. (U.S.)
- Novartis AG (Switzerland)
- Merck & Co., Inc. (U.S.)
- Sanofi (France)
- Janssen Pharmaceuticals, Inc. (Belgium)
- PurduePharma (U.S.)
- ALLERGAN (Republic of Ireland)
- Boehringer Ingelheim International GmbH (Germany)
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
